Skip to content
Research/Stem Cell Therapy/HB-adMSCs

HB-adMSCs

HB-adMSCs, or human bone-derived adipose mesenchymal stem cells, are a type of stem cell therapy derived from adipose tissue. They are being investigated for their potential to regenerate damaged tissues and modulate immune responses, which could be beneficial for longevity and health optimization. Their ability to differentiate into various cell types makes them promising for regenerative medicine.

Intelligence Profile

Clinical Applications

Adipose-derived mesenchymal stem cells (adMSCs) have been explored for a variety of clinical applications, particularly using an autologous origin. Here are key areas of research:

  1. Neurodegenerative Disorders:

    • Parkinson’s Disease: Multiple studies, including randomized clinical trials and case reports, have investigated the use of autologous adMSCs for Parkinson's disease. These studies demonstrated potential improvements in symptoms and safety profiles in both general and elderly populations, though they range from case reports to intermediate-size expanded access programs.

  2. Brain Injuries:

    • Chronic Traumatic Brain Injury: Research has suggested potential benefits from using adMSCs in promoting recovery mechanisms in individuals with chronic traumatic brain injuries. The exploration in this area is still emerging.

  3. Spinal Cord Injuries:

    • A reported case highlighted functional recovery in a quadriplegic patient following adMSC treatment, suggesting a promising avenue for future research in spinal cord injury therapies.

  4. COVID-19 and Post-COVID-19 Syndrome:

    • Studies have investigated the safety and efficacy of adMSCs in severe COVID-19 cases and for patients suffering from post-COVID-19 syndrome. An expanded access program showed promising results in post-COVID recovery.

  5. Autoimmune Disorders:

    • Systemic Lupus Erythematosus (SLE): Case reports have documented varying effects based on the frequency of adMSC administration, indicating a possible therapeutic role for severe SLE.

  6. Others:

    • Erectile Dysfunction Post-Radical Prostatectomy: A clinical trial is exploring the potential of adMSCs to treat erectile dysfunction following prostate surgery, although it is still recruiting.

Overall, the clinical applications of HB-adMSCs are diverse and cover several challenging health conditions. However, much of the current research is in early-stage clinical trials or case reports, suggesting the need for further robust trials to confirm efficacy and safety across these varied conditions.

Disclaimer: This summary is based on clinical studies and trials. Individual patient care should always be discussed with a medical professional.

Free account required

Clinical data requires a free AXIFI account to access clinical data, safety profiles, and research papers.